The cardiovascular risk of women has been the subject of particular interest in recent years, in the world, in particular under the impetus of Cardiology companies, with more and more work focusing on the specificities of these diseases in women as well as differences in terms of management and prognosis with a literature mainly based on American data and which focuses particularly on ischemic heart disease.

The expected results are to have a prevalence of PAOD in an Alsatian cohort, most of the data we currently have from American data, with analysis of the impact of specific and non-specific risk factors in this cohort and their weight in PAOD.

Inclusion criteria:

• Adult woman (≥18 years old)
• Patient hospitalized in an Intensive Cardiology Unit (ICU) at the HUS for a type 1 myocardial infarction confirmed according to the criteria of the fourth universal definition of the ESC between 01/01/2021 to 30/06/2021 inclusive
• Patient who did not express her opposition to the reuse of her data for scientific research purposes.

Exclusion criteria:

• Patient who expressed her opposition to participating in the study
• Impossibility of providing the subject with enlightened information (difficulties in understanding the subject, MMS <20/30…)
• Non-type 1 or unconfirmed myocardial infarction
• Unstable or refractory shock state at the time of the echodoppler examination
• Complication of the coronary angiography approach, in the case of femoral approach only, requiring surgical management.
• Patient under curatorship, guardianship or judicial safeguard.

Adult woman hospitalized in an Intensive Cardiology Unit (ICU) at the HUS for a type 1 myocardial infarction confirmed according to the criteria of the fourth universal definition of the ESC between 01/01/2021 to 30/06/2021 inclusive